Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe Cases
Brainimmune is Looking for a Strategic Partner to Advance the Neuroendocrine Immunology and Stress-Immunity Research Field
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Cognitive Decline and Alzheimer’s Linked to Low Systemic REST Levels and Deficient Stress Protection of the Aging Brain
New Evidence Linking Clusterin and Other Complement Proteins to Alzheimer’s Progression and PredictionSeptember 15, 2016
New Evidence Suggests Targeting Neuroinflammation May Be One Key to Slowing Alzheimer’s DiseaseAugust 16, 2016
Tumor Necrosis Factor – a Possible Link Between Age-Related Endocrine Dyscrasia and Alzheimer’s DiseaseOctober 21, 2011
Large Population Study Links Stress in Middle Age Women to Dementia and Alzheimer’s Risk Decades LaterJune 7, 2014
Blocking IL-12 and IL-23 in APPPS1 Mouse Model Shows Promise as an Experimental Therapeutic Approach to Alzheimer’s DiseaseFebruary 13, 2015
TLRs-Activated Microglia Polarizes γδ T Cells towards a Neurotoxic IL-17+ γδ T Cell Phenotype: Implications for Multiple Sclerosis, Stroke and Alzheimer´s DiseaseApril 16, 2016
New Evidence that Stress May Increase the Risk of Developing Dementia and Alzheimer’s: the Einstein Aging StudyJanuary 12, 2016
Julianne Moore Performing in Alzheimer’s Drama ‘Still Alice’ Wins Hollywood Actress AwardNovember 25, 2014
